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A combination  of the herbicide  paraquat  (PQ)  and  fungicide  maneb  (MB)  has  been  linked
to  Parkinson’s  disease.  Previous  studies  show  that this  involves  an  additive  toxicity  with
at  least  two different  mechanisms.  However,  detailed  understanding  of  mixtures  is often
difﬁcult to  elucidate  because  of  the multiple  ways  by  which  toxic  agents  can  interact.  In  the
present study,  we used  a combination  of  transcriptomics  and  metabolomics  to investigate
mechanisms  of  toxicity  of PQ and MB in a neuroblastoma  cell  line.  Conditions  were  studied
with  concentrations  of  PQ and  MB  that  each  individually  caused  20%  cell  death  and together
caused 50%  cell  death.  Transcriptomic  and  metabolomic  samples  were  collected  at time
points  prior  to signiﬁcant  cell  death.  Statistical  and  bioinformatic  methods  were  applied  to
the resulting  30,869  transcripts  and  1358  metabolites.  Results  showed  that  MB  signiﬁcantly
changed  more  transcripts  and  metabolites  than PQ,  and  combined  PQ + MB  impacted  more
than MB  alone.  Transcriptome–metabolome-wide  association  study  (TMWAS)  showed  that
signiﬁcantly changed  transcripts  and  metabolites  mapped  to two network  substructures,
one  associating  with  signiﬁcant  effects  of MB and  the  other  included  features  signiﬁcantly
associated  with  PQ + MB.  The  latter  contained  4 clusters  of  genes  and  associated  metabolites,
with one  containing  genes  for  two cation  transporters  and  a cation  transporter  regulatory
protein  also  recognized  as  a pro-apoptotic  protein.  Other  clusters  included  stress  response
genes and  transporters  linked  to cytoprotective  mechanisms.  MB  also  had a signiﬁcant
network  structure  linked  to cell  proliferation.  Together,  the results  show  that the toxicologic
mechanism  of the  combined  neurotoxicity  of  PQ and  MB  involves  network  level  interactions
and  that  TMWAS  provides  an  effective  approach  to  investigate  such  complex  mechanisms.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
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1. IntroductionHuman disease is complex, and etiologies often involve
multiple interacting factors. Loscalzo et al. [1] discussed
this in detail for sickle cell disease, in which a single
genetic mutation results in different disease phenotypes.
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Genetic epidemiology studies have consistently provided
evidence for multiple factors in disease causation, and
current understanding is that only a small fraction of non-
infectious disease burden can be directly attributed to a
genetic  cause. Willett concluded that even when speciﬁc
etiologic factors remain unclear, non-genetic factors often
account  for greater than 80% of the total attributable risk
[2].  These non-genetic factors include environmental expo-
sures  and become particularly evident when there are
dramatic changes in disease rates in a country over time
[2].  Wild introduced the term “exposome” to include all
exposures for an individual from conception to death [3].
Examples of exposures include chemicals arising from the
foods  we consume, the microbiome, pharmaceuticals and
supplements, consumer products, and industrial and agri-
cultural  chemicals [4]. To understand the contribution of
this  complex mixture of exposures to mechanisms of tox-
icity,  approaches are needed to separate and deconvolute
the effects of individual factors.
Parkinson’s disease (PD) is a multifactorial disease that
is  characterized by the progressive loss of dopaminergic
neurons of the substantia nigra pars compacta (SN). This
progressive loss of dopamine input from the SN to the
striatum results in degenerative loss of motor function
that manifests in bradykinesia, postural instability, tremor
and  rigidity [5]. This disease remains idiopathic in etiol-
ogy  due to only 5–10% of classical PD cases that result from
monogenetic mutations [5]. Epidemiological studies have
identiﬁed  that factors such as living in a rural area, consum-
ing  well water, farming, and pesticide exposure may  be risk
factors  for developing PD [7]. These observations have led
to  the development of an “environmental hypothesis” of
PD.  This hypothesis states that there are chemicals in the
environment that are capable of selectively damaging the
dopaminergic neurons of the SN, thus contributing to the
development of PD [8].
More recently, Ritz et al. have described an increased
risk of PD due to pesticide exposure [9–11]. Two com-
mon  pesticides, paraquat (PQ) and maneb (MB), have been
demonstrated in vivo to preferentially alter the nigrostri-
atal  dopamine system [12–14]. These two pesticides alone
or  in combination have also been shown to increase the risk
of  developing PD [15]. Our previous mechanistic studies of
these  two chemicals in neuroblastoma cells [16] showed
that  PQ and MB act via diverse mechanisms, with increased
combined toxicity due to an additive effect of two toxic
mechanisms.
Both  transcriptomics and metabolomics are useful omic
techniques in toxicology studies in the post-genomic era.
In  recent years, several important omics-based, toxicology-
related studies on environmental contaminants in ﬁsh
models  have been published [17–20]. In the present study,
we  used information-rich transcriptome and metabolome
analyses with advanced computational methods to study
the  additive toxic mechanisms in combined MB  and PQ
neurotoxicity in a neuroblastoma cell line. This com-
bined transcriptome–metabolome wide association study
(TMWAS) showed multiple network-level interactions.
Among the clusters of associated transcripts, two  cation
transporters and a functionally linked regulatory protein
were  increased by MB.  Each component of this transportorts 1 (2014) 435–444
network was  apparent as a hub for associated metabolites
when PQ was  also included. In the absence of MB,  metabo-
lite  clusters were not present with PQ. PQ-related changes
in  metabolism linked to multiple MB-associated transcript
changes showed that toxicity involves network-level inter-
actions.  The results further show that TMWAS  provides an
approach  to study complex mechanisms of toxicity, which
can,  in principle, be extended to study mechanisms in more
complex  in vivo systems.
2.  Materials and methods
2.1.  Cell culture
CAD  cells, mouse catecholaminergic neuronal cells,
were obtained from Health Protection Agency Culture
Collections (United Kingdom). Cells were cultured in
DMEM/F12 (1:1) with l-glutamine, 10% fetal bovine serum
and  1% penicillin/streptomycin. Cells were treated with
PQ,  MB,  or the combination of PQ and MB.  The concentra-
tions of pesticide used for each treatment group were as
follows:  PQ20 (90 M),  PQ50 (270 M),  MB20 (10.5 M),
MB50 (27 M)  or the combination of PQ and MB (90 M
PQ  + 10.5 M MB).
2.2.  Gene expression array
CAD  cells were cultured in 6-well plates and treated
for 4 h with pesticides. At the completion of the treatment
period, RNA was  isolated using a RNeasy minikit from Qia-
gen.  RNA samples (1 g total RNA) were delivered to the
Cancer Genomics Core facility at Winship Cancer Insti-
tute,  Emory University where samples were assessed for
quality  and prepared for gene expression array analysis as
per  manufacturer protocol. Three biological replicates were
used  to investigate gene expression using a mouse WG-6
array  from Illumina.
2.3.  High performance metabolic proﬁling
CAD cells were cultured in 6-well plates and treated
for 24 h with pesticides (n = 6 per treatment). Cells were
washed with PBS and 200 l of ice cold acetonitrile
(ACN) was  added to each well to precipitate protein and
extract  metabolites. Extraction conditions for the routine
metabolomics workﬂow were derived from previous stud-
ies  comparing ACN extraction and methanol extraction,
which showed that these extractions provide similar qual-
ity  data for the LC-FTMS method as used. The extracts
were collected, debris pelleted via centrifugation and
supernatants were saved for analysis. Samples were ana-
lyzed  in triplicate by LC-FTMS (Accela-LTQ Velos Orbitrap;
mass-to-charge ratio (m/z) range from 85 to 850) with
10  l injection volume using a dual chromatography setup
(anion  exchange and reverse phase (C18)) and a formic
acid/ACN gradient as described by Soltow et al. [21]. Elec-
trospray  ionization was  used in the positive ion mode. Data
were  extracted using apLCMS [22] as m/z features, where
an  m/z feature is deﬁned by m/z, RT (retention time) and
ion  intensity (integrated ion intensity for the peak). Each
sample was run in triplicate on both columns. Putative
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dentiﬁcation of metabolites was made using the Madi-
on  Metabolomics Consortium Database (MMCD) [23] and
etlin  Mass Spectrometry Database [24]. Metabolites were
dentiﬁed  via tandem mass spectrometry (MS/MS) and
atching fragmentation patterns to those of known stan-
ards.
.4.  Biostatistics and bioinformatics
Statistically  signiﬁcant gene expression and metabo-
ite intensity was determined using the R package
imma  [25] using a false discovery rate of 5% [26]. The
parse partial least squares (sPLS) regression method
27,28] implemented in the R package mixOmics was
sed  to perform integration and visualization of trans-
riptome × metabolome associations. sPLS is a variable
election and dimensionality reduction method that allows
ntegration of heterogeneous omics data from same set
f  samples; transcriptome (matrix X) and metabolome
matrix Y) data in this case where matrix X is an n × p matrix
hat  includes n samples and p genes and matrix Y is an n × q
atrix  that includes n samples and q metabolites. Variable
election for network analysis was performed by using the
op  1% of metabolites and top 5% of genes from the ﬁrst
 principal components from the sPLS analysis. Venn dia-
rams  were generated using BioVenn [29]. Gene ontology
nalysis was conducted using the Database for Annotation,
isualization and Integrated Discovery (DAVID) [30]. Sig-
iﬁcant  pathway enrichment of genes and metabolites was
chieved  using MetaCore [31]. All statistical analyses were
erformed in R.
.  Results
.1. Transcriptomic analysis
To  investigate the transcriptomic signatures of PQ, MB
nd  the combination of PQ and MB,  RNA was isolated from
AD  neuroblastoma cells after a 4 h incubation period.
his time point was selected based upon previous ﬁnd-
ngs  that the transcription factor Nrf2 was activated after a
 h treatment with PQ or MB  [16] and the desire to deter-
ine  gene expression alterations due to exposure rather
han  repair and recovery. RNA extracts were submitted
o the Emory Cancer Genomics gene array facility where
he  samples were hybridized and analyzed using a mouse
G-6  chip from Illumina. Limma  (FDR 0.05) was  used
o  determine which transcripts differed signiﬁcantly from
he  control (Supplementary Table S1). Results showed that
Q20  altered the expression of 9 genes while PQ50 altered
10.  MB changed the expression of far more genes com-
ared  to equivalent toxic doses of PQ (MB20, 573 genes;
B50, 3008 genes). The additive toxic dose of PQ20 plus
B20  altered substantially more genes (1529 genes) than
ither  PQ20 [10] or MB20 (573) alone. Thus, the extensive
ene expression changes revealed by the transcriptome
ata indicate that the cell death endpoint is a relatively poor
ndicator  of the underlying molecular processes involved in
he  toxic interaction.orts 1 (2014) 435–444 437
Supplementary material related to this article can
be  found, in the online version, at doi:10.1016/j.toxrep.
2014.07.006.
These gene expression data were subjected to principal
component analysis (PCA) (Fig. 1A). The scores plot shows
that  two general clusters were present, with one contain-
ing  control, PQ20 and PQ50, while the other included all
of  the MB-treated samples (MB20, MB50 and PQMB). A
Venn  diagram (Fig. 1B) of the unique genes altered by the
treatment conditions showed that the two  general clus-
ters  observed by PCA shared 233 genes while 77 were
unique to the PQ-group and over 3000 were unique to
the  MB-group. Using traditional concepts of additive and
synergistic interactions, one could consider the 233 shared
genes  to represent ones where additive effects could occur
while  genes changed by PQ alone or MB  alone could repre-
sent  genes contributing to synergistic effects.
Further investigation of the speciﬁc function of these
unique genes (PQ alone or MB  alone) was  conducted
via gene ontology analysis using DAVID. No signiﬁcantly
enriched functions were found in the PQ-group, but
the  MB-group included many signiﬁcantly altered func-
tions.  Some of the most signiﬁcant functions included cell
cycle  (135 genes, q = 2 × 10-11), cell cycle processes (88
genes, q = 4.2 × 10−7), DNA metabolic processes (91 genes,
q  = 9 × 10−7), protein catabolism (104 genes, q = 8.4 × 10−6),
response to cellular stress (84 genes, q = 8.4 × 10−6),
and transcription (270 genes, q = 1.3 × 10−5). Additionally,
MetaCore was  used to investigate signiﬁcant pathway
enrichment of these genes unique to each grouping. Only
one  signiﬁcant pathway, inhibition of ERK, was signiﬁ-
cantly enriched in the PQ-group. The genes unique to MB
were  signiﬁcantly enriched in 139 different pathways and
similar  to the gene ontology investigation using DAVID; the
top  6 signiﬁcant pathways all involve the cell cycle and cell
cycle  regulation. These analyses did little to clarify the pre-
vious  conclusion [16] that combined additive toxicity of
PQ  and MB  involves combination of different toxicological
mechanisms.
3.2. Metabolomic analysis
To  assess alterations in the metabolome due to PQ,
MB  and PQ + MB treatments, cells were treated for 24 h
to  ensure that gene transcription, protein translation and
enzymatic activity could occur and a metabolic signature
could be evaluated. Metabolites were extracted using ace-
tonitrile  and these extracts were analyzed using a high
performance metabolic proﬁling workﬂow as previously
described [21]. Metabolites were separated using C18 chro-
matography and ions were detected using a LTQ-Velos
Orbitrap mass spectrometer. After data extraction using
apLCMS [22], the data were ﬁltered to include only the
ions  (m/z) with a coefﬁcient of variation (%CV) of less than
10%.  Limma  (FDR 0.05) was  used with the resulting 1358
ions  to select metabolites that were signiﬁcantly differ-
ent  from control samples. Analysis of PQ-treated samples
showed that PQ20 and PQ50 altered 21 and 464 metabo-
lites, respectively. Similar to the transcriptome results,
MB  altered the intensity of many more metabolites com-
pared  to control (MB20, 352; MB50, 590). Importantly, the
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Fig. 1. Transcriptomic data reveal toxicant-speciﬁc data clustering and gene expression. Principal component analysis (A) shows two distinct groupings
2) and M
 of gene
where  control, PQ20, and PQ50 project along principal component 2 (PC
concentration  dependent manner. Venn diagram (B) displays the number
toxicant  treatment.
combination of PQ20 and MB20 altered 454 metabolites,
greater than PQ20 [22] or MB20 (352) alone.
The metabolomics data were also evaluated using PCA
(Fig.  2A) and provided results similar to the transcriptome
data. Two distinct clusters were present that included con-
trol,  PQ20 and PQ50 in one cluster and the MB  treated
samples (MB20, MB50, PQMB) in the other. A Venn dia-
gram  of the metabolomics data (Fig. 2B) showed that
129  m/z  were unique to the PQ-group, 397 m/z unique to
the  MB-group and 334 m/z shared by both. The lists of
m/z  unique to the two groups were matched to KEGG
identiﬁers (ID) by searching the Metlin database for the fol-
lowing  adducts: M+H, M+Na, M+K, M+H–H2O, M+H–2H2O,
M+ACN+H. These KEGG ID were then used with Meta-
Core for pathway enrichment analysis. Using the KEGG ID
unique  to the PQ group, signiﬁcant enrichment was  found
in  various pathways such cholesterol and sphingolipid
transport (−Log P = 13.096), pathways of His, Glu, and
Gln  metabolism (−Log P = 3.962), and tyrosine metabolism
(−Log P = 2.213). Pathways signiﬁcantly enriched in the
MB-group included estrogen biosynthesis (−Log P = 5.219)
and  pathways of branched chain amino acid (Leu, Ile, Val)
metabolism (−Log P = 2.978). Thus, the metabolomics data
were  consistent with the interpretation that additive MB
and  PQ toxicity is due to different mechanisms of toxicity.
3.3.  Integration of transcriptome and metabolome
To investigate the gene and metabolite interactions
occurring due to MB  and paraquat interaction, we
examined interactions for the PQ20, MB20 and PQMB
transcriptome and metabolome data using the sPLS
method implemented in the mixOmics R package (details
in  Section 2). An association network comprising of 340
metabolites and 7625 genes was generated at a threshold
of  0.5 for association score using sPLS. The overall inter-
action network showed three major substructures (Fig. 3).
One  substructure [1] was very dense suggesting an overall
homogeneity of most interactions. This substructure hadB20, MB50, and PQMB project along principal component 1 (PC1) in a
s common between groups as well as the number of genes unique to each
distal  associations with the other more diffuse and less
dense  substructures [2,3]. Substructure 2 had few inter-
mediate elements connecting with Substructure 1, while
Substructures 2–3 and 1–3 had many intermediate ele-
ments. This relationship suggests that Substructure 2 may
represent  a second-order interaction with Substructure 1
linked  principally through Substructure 3.
Substructure detail was further investigated by sequen-
tially imposing ﬁlters for the number of hub genes and
strength of gene–metabolite associations using association
scores from sPLS. With 500 hub genes and 0.5 as a threshold
ﬁlter for association score, the large dense cluster contain-
ing  most of the genes and metabolites was lost and only 2
subclusters remained (not shown). With higher stringency
(500  hub genes and a threshold of 0.7), this substructure
was  preserved (Fig. 3B) and only a small number of metabo-
lites  connected the hub genes. Restriction to the top 50
hub  genes (Fig. 3C) simpliﬁed these relationships, and man-
ual  searching of the genes against Supplementary Table S1
showed  that both modules in Fig. 3C contained genes sig-
niﬁcantly associated with MB  treatment as visualized in
Fig.  1. Importantly, the smaller module in Fig. 3C (Top clus-
ter)  contained metabolites associated with PQMB and not
MB  alone or PQ alone. Thus, the interaction of the transcrip-
tome and metabolome data has a network organizational
structure linked to MB  treatment with additional distin-
guishing transcript–metabolite modules speciﬁcally linked
to  PQ in MB-treated cells.
Examination  of the PQMB module showed that 4 clus-
ters  (Cluster 1: Chac1, Slc11a1, Slc30a1; Cluster 2: Gpt2,
Slc1a4, Slc7a11; Cluster 3: Pparg, Slc6a9; Cluster 4: Hmox1,
Mt1,  Srxn1) were present among 13 genes (Fig. 4). Cluster
1  contained two cation transporters and Chac1, a homolog
of  E. coli cation-transporter regulator-1. Chac1 is a proapo-
ptotic  protein of the unfolded protein response pathway
[32] that has glutamylcyclotransferase activity speciﬁc
for  glutathione [33]. Slc11a1 is a divalent cation trans-
porter with activity for iron and manganese, and Slc30a1
is  a zinc transporter. Thus, Cluster 1 is a cation-related
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Fig. 2. Metabolomic data demonstrates toxicant-speciﬁc clustering and metabolite patterns. Principal component analysis (A) shows two distinct groupings
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hhere  control, PQ20, and PQ50 project along principal component 1 (PC1
ependent  manner. Venn diagram (B) displays the number of genes com
reatment.
ene-metabolite response cluster with known activities,
hich could contribute to combined PQMB toxicity. The
etabolites positively and negatively associated with Clus-
er  1 were largely the same as those for Clusters 2 and 3 so
hese  are discussed together below.
Cluster 2 included genes encoding a module associ-
ted with amino acid transport and metabolism: Gpt2
glutamate–pyruvate transaminase), an enzyme catalyz-
ng  reversible transamination of glutamate and pyruvate in
mino  acid metabolism and gluconeogenesis; Slc1a4 (glu-
amate/neutral amino acid transporter) and Slc7a11 (light
hain,  xc− system). The xc− system supports supply of pre-
ursors  Glu and cystine for GSH synthesis, so this may
epresent a response to oxidative stress.
Cluster 3 included peroxisome proliferator-activated
eceptor gamma  (PPAR-; Pparg) and a glycine transporter,
lc6a9. PPAR- is a nuclear receptor that forms het-
rodimers with retinoid X receptors (RXRs) and regulates
ranscription of various genes, especially involved in fatty
cid  storage and glucose metabolism. Glycine increases
PAR- expression [34], suggesting that this could also be
art  of an adaptive or protective response rather than a
oxic  response.
Finally, Cluster 4 contained stress response genes,
eme oxygenase-1 (Hmox1), metallothionein-1 (Mt1), and
ulﬁredoxin-1 (Srxn1), which respond to a range of cell
tresses including oxidative stress and metal toxicities.
ogether, the genes and associated metabolites represent
 network response for PQMB toxicity rather than a single
olecular target of toxicity for either PQ or MB.
Database matches to the metabolites positively and
egatively correlating with all four clusters were largely
he  same and are summarized in Table 1; PPAR-
ad the largest number of associations >|0.3|. Co-
nzyme metabolites associated with mitochondrial func-
ion  and energy metabolism included methylnicotinamide,
iboﬂavin, thiamine and vitamin D, which were positively
ssociated, and pyridoxamine, pantetheine, 2-(alpha-
ydroxyethyl)thiamine diphosphate and dihydropteroate,B20, MB50, and PQMB project along both PC1 and PC2 in a concentration
etween groups as well as the number of genes unique to each toxicant
which were negatively associated. Methylnicotinamide is a
methylated  product derived from NAD and is also derived
from  polyADP-ribose polymerase activation, involved in
regulation  of chromatin structure and activation of cell
death.  Dihydropteroate is an intermediate in 1-carbon
metabolism, and other 1-carbon metabolism intermediates
also had negative association, including methionine (Met)
and  S-adenosylhomocysteine. One-carbon metabolism is
important  in nucleotide metabolism, and both pyrimi-
dine (cytosine, dCDP, dihydrouracil, dihydroorotate)- and
purine  (hypoxanthine)-related metabolites varied in asso-
ciation  with the 13 transcripts (Table 1).
In addition to the amino acid metabolites indicated
above, multiple cationic amino acid (Lys, His) metabo-
lites were associated, both positively and negatively, with
the  transcripts. Notably, phenylalanine (Phe) metabolites
were positively associated with the transcripts; phenyl-
alanine has been previously associated with changes in
PPAR-  expression. Along with Met, Phe, Lys and His
above, methylpyrrolinium is metabolically linked to acety-
lornithine, which is a component of the urea cycle and
used  by mitochondria as a precursor for arginine (Arg)
and  citrulline. Other negative associations included thre-
onine  and metabolites of tryptophan (indoleacetate) and
branched chain amino acids (methyl-2-oxopentanoic acid).
Thus,  the data show a generalized association of essential
amino acids and related metabolites to changes in PPAR-
and  other associated transcripts.
Associations with energy intermediates were also
present (Table 1). Several metabolites related to lipid
metabolism were also negatively associated. Consistent
with earlier studies of PQ-induced toxicity, the antioxidant
-tocopherol and the GSH precursor, -glutamylcysteine
were negatively associated with the transcripts.
The larger module from Fig. 3C with hub genes and
metabolites principally associated with MB  was  enriched
in  genes functioning in cell cycle regulation (Fig. 5).
Metabolites associated with this hub overlapped with the
metabolites associated with the 13 transcripts but did
440 J.R. Roede et al. / Toxicology Reports 1 (2014) 435–444
nscripto
nes (thrFig. 3. Toxicological response networks generated via integration of tra
metabolites,  (B) top 500 hub genes (0.7 threshold), and (C) top 50 hub ge
not have clearly discernible pathway associations. Surpris-
ingly,  there were no apparent associations with pyrimidine
bases, dCDP or hypoxanthine. Similarly, there was no
apparent association with 1-carbon metabolism energy
metabolism or other amino acid degradation products.
There were weak associations of some of the genes with
the  polyamine, spermine.
4.  DiscussionThe etiology of PD is complex and the overwhelming
majority of cases are idiopathic in nature. Exposures to
environmental chemicals, like pesticides, have been linkedmic and metabolomic data. These networks represent (A) all genes and
eshold 0.7).
to  an increased risk of PD [6,7]. In regards to human expo-
sure  to PQ and MB,  Costello et al. have reported that
residential exposure to PQ or MB  from agricultural appli-
cations resulted in an odds ratio of 2.27, while those who
reported exposure to both PQ and MB had an odds ratio
of  4.17 [15]. Additionally, ambient exposure to a combi-
nation of ziram, MB  and PQ resulted in an odds ratio of
3.09  [10]. In vivo and in vitro studies have also demon-
strated the neurotoxic properties of PQ and MB.  In mice,
repeated exposure to PQ and MB  results in the loss of
tyrosine hydroxylase positive neurons, decreased striatal
dopamine levels, and behavioral deﬁcits [12,14]. In vitro
studies  have also demonstrated that MB can enhance the
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Fig. 4. Transcriptome–metabolome associations present the PQMB module. 13 genes present in the PQMB module are displayed (A). Cluster 1 (B), Cluster
2  (C), Cluster 3 (D), and Cluster 4 (E) are also displayed.
Table 1
Metabolites associated with four transcript clusters (Fig. 4) changed by paraquat in maneb-treated cells. Metabolite matches were obtained by searching
the  Metlin database with high resolution m/z within 10 ppm. Associations were similar for all genes and clusters and are summarized together for those
with  positive and negative associations. PPAR- in cluster 3 was  most representative and associated metabolites are noted with an asterisk (*).
Pathways Positive Adduct m/z Negative Adduct m/z
Coenzyme
metabolism
*Methylnicotinamide M+H  137.0718 *Pyridoxamine M 168.0887
Riboﬂavin M+H  377.1441 Pantetheine M+HCOONa 347.1247
Thiamine M(C13)+H 267.1219 *2-(alpha-Hydroxyethyl)thiamine diphosphate M(C13)+2H 236.1191
Vitamin  D3 M+NH4 402.3723 *Dihydropteroate M+Na 337.1007
Nucleoside
metabolism
*Cytosine M+H  112.0501 dCDP M+2H 195.0156
*Hypoxanthine M(C13)+H 138.0482 *Dihydrouracil M+2Na–H 173.0298
*Dihydroorotate M(C13)+H 160.0420
Amino acid
metabolism
*Methylpyrrolinium M+HCOONa 153.0765 *Methionine M+NH4 167.0860
*Acetylornithine M+2H 88.0574 *Threonine M+H  120.0650
*Dicarboxypropyllysine M+2H 139.0733 *N-Acetyl-l-glutamate 5-semialdehyde M(S34)+H 176.0703
*Hydroxyindoleacetaldehyde M(C13)+H 89.0413 Oxoadipate M+H  160.0372
*Phenylpyruvate M+H  165.0541 *Urocanate M(S34)+H 141.0458
*Phenylacetate M+H–H2O 119.0485 *Indoleacetic acid M+H  236.0273
*Methyl  oxopentanoic acid M+HCOOK 215.5285
*Imidazole-4-acetaldehyde M+H  111.0547
*S-Adenosylhomocysteine M+HCOONa 453.1135
Antioxidant
systems
*-Tocopherol M+H  431.3903
*-Glutamylcysteine M+H–H2O 233.0591
Energy
metabolism
Oxaloacetate M+2Na 88.9925 Phosphoenolpyruvate M 167.9816
*Lactate  M+2Na–H 135.0023
*Creatinine  M+ACN+Na 177.0731
Lipid
7-Dehydrocholesterol M+NH4 402.3723 Glycerol M+K  131.0110
Glycerol  1-P M+ACN+Na 236.0273
*O
*S
*S
t
e
t
d
bmetabolism
oxicokinetics of PQ [35], which may  contribute to the
nhanced neurotoxicity observed in vivo when both pes-
icides  are administered in combination. Together, these
ata  demonstrated that pesticides, in particular the com-
ination of PQ and MB,  increase the risk of developing PDxooctanoyl-CoA M(C13)+2H 455.1100
phingosine or dehydrosphinganine M+Na 322.2698
phingosine 1-P M+H–H2O 334.2125
in  humans, and in vitro and in vivo studies have brought to
light  prospective mechanisms of toxicity.
In a previously published study [16], we characterized
the individual mechanisms involved in PQ, MB,  and PQMB
toxicity  in vitro. Using SH-SY5Y neuroblastoma cells, we
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ations aFig. 5. Network structure and gene/metabolite associ
observed that PQ and MB  act via distinct redox mecha-
nisms. For example, PQ caused increased ROS production,
oxidation of mitochondrial thioredoxin 2 and peroxire-
doxin 3, lesser oxidation of cytoplasmic thioredoxin 1 and
peroxiredoxin 1, and no oxidation of cellular GSH/GSSG. In
contrast,  MB alone at a similar toxic dose did not cause ROS
production or oxidation of thioredoxin or peroxiredoxin
isoforms as observed with PQ. MB  treatment did cause an
increase  in cellular GSH, which was attributed to the ability
of  MB  to cause nuclear localization of Nrf2 and transcrip-
tional activation. The results of these studies showed that
MB  potentiation of PQ-mediated neurotoxicity does not
occur  via enhancement of oxidative stress, but suggests
that increased toxicity can be attributed to a combination ofssociated with genes involved in cell cycle regulation.
divergent  mechanisms that perhaps involve PQ-mediated
oxidation and thiol alkylation by MB [36]. The present stud-
ies  clarify and extend these data by showing that multiple
network responses are involved in the combined neuro-
toxic  response. As discussed below, a toxic cation-response
hub (Cluster 1) co-exists with an amino acid/antioxidant
response hub (Cluster 2), an adaptive PPAR- response
hub (Cluster 3) and an early Hmox-1 stress-response hub
(Cluster  4). Note that this clustering is deﬁned by the inter-
action  network of the transcriptome and metabolome and
therefore  cannot be assumed to reﬂect transcription factors
functioning independently.
Transcriptomic analyses of CAD cell response to PQ, MB,
or  PQMB showed that expression of substantially more
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enes were altered in response to MB treatment com-
ared to control or PQ treated cells. PCA analysis of this
ata  shown in Fig. 1A revealed two groupings: one that
ncluded all MB treated cells (MB20, MB50, PQMB) and
he  other that included both PQ treatments (PQ20, PQ50)
nd  the controls. This result shows that (1) few signiﬁcant
ffects are observed with PQ alone due to the clustering
ith control samples and (2) supports our previously pub-
ished  research describing two divergent mechanisms in
hich  MB  increased GSH while PQ caused GSH oxidation
16]. Also consistent with these previous studies, some
f  the most signiﬁcantly altered genes in the MB  treated
roups were genes regulated by the Nrf2-Keap-1 system.
hese genes included heme oxygenase-1, sulﬁredoxin-1,
nd Slc7a11. All of the Nrf2-regulated genes were increased
n  a concentration dependent manner and the expression in
he  PQMB group was slightly higher than that of the MB20
roup.  It should also be noted that these Nrf2-regulated
enes were not signiﬁcantly changed in the groups treated
ith  only PQ. Metabolomics data showed very similar pat-
erns  to transcriptomic data. For example, MB treatments
igniﬁcantly changed many more metabolites compared to
Q  treatments and controls. PCA analysis was also similar to
hat  found in the transcriptomic data (Fig. 2A). Two  group-
ngs  were observed and the pattern was identical to the
ene  expression data, where MB treated samples (MB20,
B50, PQMB) formed one group and the second group
onsisted of the PQ-only treated samples and the controls.
ogether, the transcriptomic and metabolomics data are in
greement  and further suggest that distinct mechanisms
re involved with each toxicant.
Metabolomic data, in combination with the transcrip-
ome data, show that the toxicologic mechanism for the
ombined toxicity of PQ and MB occur at a network
evel. Without PQ, MB  caused extensive changes in gene
xpression associated with cell cycle, but without readily
iscernible pathway effects. Without MB,  PQ had little dis-
ernable  character to effects on either the transcriptome
r the metabolome. However, in cells treated with MB,  a
ew  network structure was apparent with PQ that included
3  transcripts with multiple associated groups of metabo-
ites.  These groups included metabolites associated with
xidative stress and mitochondrial energy metabolism,
onsistent with prior ﬁndings concerning GSH concentra-
ion and oxidative stress effects on GSH and thioredoxin
edox systems. Additionally, the associations included
xtensive effects on essential amino acid metabolism and
-carbon  metabolism.
Together with previous evidence, the combined trans-
riptomic and metabolomic data clarify mechanisms
nderlying the combined toxicities of MB and PQ. Specif-
cally,  the data show that MB  has broad effects on
ranscription, especially affecting cell cycle genes and
ausing a new set point for nuclear functions. Among
he transcripts changed, three related to cation transport
ppear to be especially important to enhance uptake of
araquat and oxidative metals. Mitochondrial dysfunc-
ion and oxidative stress are apparent in the metabolome.
etwork effects are apparent from the changes in amino
cid  metabolism, energy metabolism and lipid metabolism.
mportantly, these include metabolites of phenylalanineorts 1 (2014) 435–444 443
previously associated with PPAR- activation. Schu-
macher et al. showed that high Phe activated peroxisome
proliferator-activated receptor- (PPAR-) and changed
gene expression in a manner comparable to the PPAR-
agonist, rosiglitazone [37]. Associated inhibition of cell pro-
liferation  led to the conclusion that neurodevelopmental
effects of Phe in PKU may  occur due to interruption of PPAR-
  signaling. The extrapolation of results from our in vitro
studies to in vivo effects must be made with caution, how-
ever,  because of the single time points used for analysis. The
selection  of time points was made in an attempt to optimize
ﬁndings based upon previous studies, and more complete
time course data will be needed to fully understand the
temporal nature of the network responses.
The present study emphasizes the need to approach
environmental contributions to human disease within a
complex  systems approach to human pathobiology. The
simplistic paradigm of additive and synergistic mecha-
nisms of toxicity, which we previously used to interpret
the interactions of MB  and PQ toxicity, are inadequate to
address  the multiple network level interactions revealed
by  the combined TMWAS. With the availability of powerful
omic  tools, investigation of such network level interac-
tions can be expected to provide new means to detect
adverse human exposures, improve understanding of criti-
cal  underlying mechanisms, and facilitate remediation and
therapeutic  strategies to minimize human toxicity.
In summary, the present study used a combination of
transcriptomics and metabolomics to investigate mecha-
nisms  of toxicity of PQ and MB  in a neuroblastoma cell
line.  The results show that the toxicologic mechanism
of the combined neurotoxicity of PQ and MB  involves
network level interactions with effects on proliferation,
transport systems and fundamental metabolic pathways
of  intermediary metabolism. Importantly, the combination
of  transcriptomics and metabolomics (TMWAS) provides
an  effective approach to investigate complex toxicologic
mechanisms.
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